Takeda Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019	2018	2017
Cash & Equivalents	533,530	849,695	966,222	637,614	702,093	294,522
Short-Term Investments	20,174	25,305	36,598	15,822	23,276	80,646
Cash & Cash Equivalents	553,704	875,000	1,002,820	653,436	725,369	375,168
Cash Growth	-36.72%	-12.75%	53.47%	-9.92%	93.35%	-
Receivables	649,429	696,644	783,091	757,005	741,907	420,247
Inventory	986,457	853,167	753,881	759,599	919,670	212,944
Other Current Assets	208,366	168,831	173,101	299,392	606,091	70,449
Total Current Assets	2,397,956	2,593,642	2,712,893	2,469,432	2,993,037	1,078,808
Property, Plant & Equipment	1,691,229	1,582,800	1,453,917	1,386,370	1,331,931	536,801
Long-Term Investments	378,857	330,133	348,350	369,455	299,922	304,385
Goodwill and Intangibles	9,060,380	8,226,293	7,943,023	8,183,889	8,991,420	2,043,512
Other Long-Term Assets	429,328	445,150	454,110	411,948	176,463	142,957
Total Long-Term Assets	11,559,794	10,584,376	10,199,400	10,351,662	10,799,736	3,027,655
Total Assets	13,957,750	13,178,018	12,912,293	12,821,094	13,792,773	4,106,463
Accounts Payable	649,233	516,297	343,838	318,816	327,394	240,259
Current Debt	525,137	400,064	270,206	682,523	1,032,146	29,631
Other Current Liabilities	1,307,570	1,229,369	1,159,132	1,174,559	1,193,509	467,619
Total Current Liabilities	2,481,940	2,145,730	1,773,176	2,175,898	2,553,049	737,509
Long-Term Debt	4,577,010	4,610,361	5,130,895	4,905,616	5,006,220	1,076,867
Other Long-Term Liabilities	544,128	738,404	831,045	1,012,094	1,047,513	274,678
Total Long-Term Liabilities	5,121,138	5,348,765	5,961,940	5,917,710	6,053,733	1,351,545
Total Liabilities	7,603,078	7,494,495	7,735,116	8,093,608	8,606,782	2,089,054
Total Debt	5,102,147	5,010,425	5,401,101	5,588,139	6,038,366	1,106,498
Debt Growth	1.83%	-7.23%	-3.35%	-7.46%	445.72%	-
Retained Earnings	1,541,146	1,479,716	1,509,906	1,369,972	1,595,431	1,557,307
Comprehensive Income	0	0	0	0	0	-4,795
Shareholders' Equity	6,354,122	5,683,019	5,173,037	4,723,483	5,181,985	1,997,424
Net Cash / Debt	-4,548,443	-4,135,425	-4,398,281	-4,934,703	-5,312,997	-731,330
Working Capital	-83,984	447,912	939,717	293,534	439,988	341,299
Book Value Per Share	2049.24	1817.57	1660.40	1509.09	3307.01	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).